Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Pancreatic Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04913337
What this trial is testing

Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
MesotheliomaGlioblastomaRenal Cell Carcinoma+12 more
NGM Biopharmaceuticals, Inc 179
Large-scale testing (Phase 3)UnknownNCT04931381
What this trial is testing

Organoid-Guided Chemotherapy for Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Cancer
Changhai Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07736612
What this trial is testing

A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerRAS Mutations or Amplifications
Zhejiang University 80
Early research (Phase 1)Study completedNCT01764477
What this trial is testing

Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Advanced Pancreatic CancerMetastatic Pancreatic CancerPancreatic Adenocarcinoma
Prism Pharma Co., Ltd. 20
Early research (Phase 1)Looking for participantsNCT05365581
What this trial is testing

ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 398
Early research (Phase 1)Active Not RecruitingNCT06607185
What this trial is testing

The Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerColorectal Cancer+2 more
Eli Lilly and Company 750
Testing effectiveness (Phase 2)Looking for participantsNCT06333314
What this trial is testing

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

Who this might be right for
Pancreatic AdenocarcinomaAmpulla of Vater CarcinomaAdrenocortical Carcinoma+5 more
UNICANCER 120
Early research (Phase 1)Ended earlyNCT04025216
What this trial is testing

CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

Who this might be right for
Non-Small Cell Lung CancerOvarian CancerFallopian Tube Cancer+3 more
Kite, A Gilead Company 16
Early research (Phase 1)UnknownNCT02433626
What this trial is testing

Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies

Who this might be right for
Ovarian CancerFallopian Tube CancerEndometrial Cancer+7 more
Critical Outcome Technologies Inc. 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06513455
What this trial is testing

Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Harbin Medical University 132
Not applicableStudy completedNCT02292745
What this trial is testing

Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer.

Who this might be right for
Pancreatic Neoplasms
Foundation for Liver Research 53
Early research (Phase 1)WithdrawnNCT04270929
What this trial is testing

Pressure Enabled Drug Delivery By Pancreatic Retrograde Venous Infusion For Advanced Pancreatic Carcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Roger Williams Medical Center
Testing effectiveness (Phase 2)Study completedNCT00366457
What this trial is testing

Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdenocarcinoma of the Pancreas
Massachusetts General Hospital 32
Post-approval studies (Phase 4)WithdrawnNCT02570529
What this trial is testing

Prevention of Upper Gastrointestinal Hemorrhage Using Albis® in the Patients of Locally Advanced Pancreatic Cancer Who Underwent Concurrent Chemoradiotherapy

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Yonsei University
Early research (Phase 1)Study completedNCT01413022
What this trial is testing

FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Neoplasms
Washington University School of Medicine 44
Early research (Phase 1)Looking for participantsNCT06182072
What this trial is testing

ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
ProDa BioTech, LLC 46
Not applicableStudy completedNCT05078775
What this trial is testing

Medical Food for the Dietary Management of Advanced/Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaLocally Advanced Unresectable Pancreatic Adenocarcinoma
Faeth Therapeutics 39
Early research (Phase 1)Study completedNCT00885066
What this trial is testing

Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Centre Antoine Lacassagne 30
Large-scale testing (Phase 3)Looking for participantsNCT06943755
What this trial is testing

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Who this might be right for
Pancreatic Neuroendocrine Tumor (pNET)Extra-Pancreatic Neuroendocrine Tumor (epNET)
Exelixis 440
Not applicableLooking for participantsNCT07799935
What this trial is testing

IRE After Chemotherapy for Locally Advanced Pancreatic Cancer

Who this might be right for
IRE
Tianjin Medical University Cancer Institute and Hospital 60
Next Page